Viewing Study NCT05902494


Ignite Creation Date: 2025-12-25 @ 1:45 AM
Ignite Modification Date: 2025-12-26 @ 2:36 AM
Study NCT ID: NCT05902494
Status: COMPLETED
Last Update Posted: 2025-07-20
First Post: 2023-06-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: HER2 and LA/mUC: A Multi-country Chart Review Cohort Study
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-06-29
Start Date Type: ACTUAL
Primary Completion Date: 2025-06-18
Primary Completion Date Type: ACTUAL
Completion Date: 2025-06-18
Completion Date Type: ACTUAL
First Submit Date: 2023-06-05
First Submit QC Date: None
Study First Post Date: 2023-06-15
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-07-17
Last Update Post Date: 2025-07-20
Last Update Post Date Type: ACTUAL